|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM359197280 |
003 |
DE-627 |
005 |
20231226080348.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2023 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.3928/23258160-20230614-01
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1197.xml
|
035 |
|
|
|a (DE-627)NLM359197280
|
035 |
|
|
|a (NLM)37418667
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Vagaggini, Tommaso
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Clinical Factors and Outcomes of Acute-Onset Endophthalmitis Following Small-Gauge Pars Plana Vitrectomy Surgery
|
264 |
|
1 |
|c 2023
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 21.07.2023
|
500 |
|
|
|a Date Revised 22.07.2023
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a BACKGROUND AND OBJECTIVES: Describe risk factors, findings, and outcomes of acute endophthalmitis (AE) following small-gauge pars plana vitrectomy (PPV)
|
520 |
|
|
|a PATIENTS AND METHODS: This was a retrospective single-center, nonrandomized study of post-PPV AE patients from 2013 to 2021. All received vitreous biopsy before treatment. Patients were divided into cohorts: 1) PPV within 3 days of diagnosis (Urgent-PPV), and 2) no urgent PPV (Other-treatment [Tx]). Main outcome was best-corrected visual acuity (BCVA) at 6 months
|
520 |
|
|
|a RESULTS: Twenty-one patients were analyzed. Epiretinal membrane was the most common indication for PPV (48%). Incidence was 0.074%. Culture-positive rate was 57%. For final BCVA, there was no significant (P = 0.85) difference between Urgent-PPV (median = 0.40 logMAR) and Other Tx cohorts (median = 0.35 logMAR). Sclerotomy wounds were not sutured in 71% of patients. Approximately 24% and 38% of patients analyzed had either no tamponade or partial tamponade, respectively
|
520 |
|
|
|a CONCLUSION: Tamponade agents and sclerotomy suturing may be important factors when evaluating post-small-gauge PPV-associated AE. Further studies are necessary for clarification. [Ophthalmic Surg Lasers Imaging Retina 2023;54:395-400.]
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
700 |
1 |
|
|a Adams, Olufemi E
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Curran, Christian D
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Prairie, Michael L
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Baker, Mikayla J
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sastry, Ananth
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ryan, Edwin H
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Parke, D Wilkin
|c 3rd
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mittra, Robert A
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tang, Peter H
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Ophthalmic surgery, lasers & imaging retina
|d 2013
|g 54(2023), 7 vom: 09. Juli, Seite 395-400
|w (DE-627)NLM224956647
|x 2325-8179
|7 nnns
|
773 |
1 |
8 |
|g volume:54
|g year:2023
|g number:7
|g day:09
|g month:07
|g pages:395-400
|
856 |
4 |
0 |
|u http://dx.doi.org/10.3928/23258160-20230614-01
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_63
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_90
|
912 |
|
|
|a GBV_ILN_91
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_135
|
912 |
|
|
|a GBV_ILN_136
|
912 |
|
|
|a GBV_ILN_151
|
912 |
|
|
|a GBV_ILN_181
|
912 |
|
|
|a GBV_ILN_203
|
912 |
|
|
|a GBV_ILN_217
|
912 |
|
|
|a GBV_ILN_235
|
912 |
|
|
|a GBV_ILN_289
|
912 |
|
|
|a GBV_ILN_294
|
912 |
|
|
|a GBV_ILN_297
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_352
|
912 |
|
|
|a GBV_ILN_674
|
912 |
|
|
|a GBV_ILN_676
|
912 |
|
|
|a GBV_ILN_688
|
912 |
|
|
|a GBV_ILN_698
|
912 |
|
|
|a GBV_ILN_721
|
912 |
|
|
|a GBV_ILN_737
|
912 |
|
|
|a GBV_ILN_791
|
912 |
|
|
|a GBV_ILN_812
|
951 |
|
|
|a AR
|
952 |
|
|
|d 54
|j 2023
|e 7
|b 09
|c 07
|h 395-400
|